Hereditary Coproporphyria: An Imitator of Multiple Sclerosis

ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Volume 72, Issue 9, Macy JA, Gilroy J, Perrin JC

​

Sodium and Chloride Depletion in Acute Porphyria with Reference to the Status of Adrenal Cortical Function

​

Acute Intermittent Porphyria: An Unusual Cause of Malignant Hypertension

​

Porphyria 

​

Tissue-Specific Expression of Aminolevulinic Acid Synthase–1 and Heme Oxygenase–1 and Their Expression in Livers of Rats Chronically Exposed to Ethanol 

​

Neonatal-Onset Hereditary Coproporphyria with Male Pseudohermaphrodism 

​

Nuclear Receptor 5A (NR5A) Family Regulates 5-Aminolevulinic Acid Synthase 1 (ALAS1) Gene Expression in Steroidogenic Cells 

​

Individualized Workup: a New Approach to the Biochemical Diagnosis of Acute Attacks of Neuroporphyria

​

Premenstrual Attacks of Acute Intermittent Porphyria Hormonal and Metabolic Aspects: a Case Report 

​

Acute Intermittent Porphyria Treated by Testosterone Implant 

​

Acute Intermittent Porphyria: Case Report and Review of Literature 

​

ALAD Porphyria Is a Conformational Disease

​

Coexistence of Systemic Lupus Erythematosus and Severe Hepatic Porphyria 

​

Acute Intermittent Porphyria Presenting as Acute Muscle Pain, Fever, and Weakness 

​

Cimetidine in the Treatment of Acute Intermittent Porphyria from Onset to Death 

​

The Severity of Hereditary Porphyria is Modulated by the Porphyrin Exporter and Lan Antigen ABCB6 

​

Clinical Manifestations and Diagnostic Challenges in Acute Porphyrias 

​

Acute Intermittent Porphyria: Clinical and Selected Research Aspects 

​

Neurovisceral Porphyrias: What a Hematologist Needs to Know 

​

Acute Intermittent Porphyria: A Diagnostic Challenge for Endocrinologist 

​

A Skin disease, A Blood Disease or Something in Between: an Exploratory Focus Group Study of Patients Experiences with Porphyria Cutanea Tarda 

​

Role of Two Nutritional Hepatic Markers (insulin-like growth factor 1 and transthyretin) in the Clinical Assessment and Follow-up of Acute Intermittent Porphyria Patients

​

Porphyria's

​

Clinical and Laboratory Features of Acute Porphyria: A Study of 36 Subjects in a Chinese Tertiary Referral Center 

​

​

Acute Intermittent Porphyria in Two Patients on Anticonvulsant Therapy and with Normal Erythrocyte Porphobilinogen Deaminase Activity 

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Volume 27, Issue 4, Herrick AL, McColl KEL, Moore MR, Brodie MJ, Adamson AR, Goldberg A
DOI: 10.1111/j.1365-2125.1989.tb05398.x

​

Homozygous Variegate Porphyria: Twenty Year Follow-Up and Characterization of Molecular Defect 

JOURNAL OF INVESTIGATIVE DERMATOLOGY

Volume 116, Issue 4, Kauppinen R, Timonen K, von und zu Fraunberg M, Laitinen E, Ahola H, Tenhunen R, Taketani S, Mustajoki P

DOI: 10.1046/j.1523-1747.2001.01293.x

​

Circadian Rhythms in Acute Intermittent Porphyria: a Pilot Study 

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Volume 43, Issue 7, Larion S, Caballes FR, Hwang S, Lee JG, Rossman WE, Parsons J, Steuerwald N, Li T, Maddukuri V, Groseclose G, Finkielstein CV, Bonkovsky HL

DOI: 10.1111/eci.12102

​